Inventor · disambiguated record
Aleardo Koverech
Also filed as: KOVERECH ALEARDO
18 granted patents·18 pending applications·26 citations·filing 2001–2020
89Inventor score
Files withSIGMA TAU IND FARMACEUTI23KOVERECH ALEARDO6ALFASIGMA SPA1CAVALLINI GIORGIO1GRILLI MARIAGRAZIA1
Top patents by PatentIndex Score
36 records- 0191US8389014B2Gel useful for the delivery of ophthalmic drugsLONGO ANTONIO·Filed 2007·Granted Mar 5, 2013·14 cites·2 claims
- 0282US7655698B2Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for opthalmic use in the form of eye dropsSIGMA TAU IND FARMACEUTI·Filed 2006·Granted Feb 2, 2010·7 cites·7 claims
- 0375US8158679B2Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseasesKOVERECH ALEARDO·Filed 2007·Granted Apr 17, 2012·1 cites·3 claims
- 0471US8377988B2Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye dropsSIGMA TAU IND FARMACEUTI·Filed 2009·Granted Feb 19, 2013·1 cites·2 claims
- 0570US8003652B2Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunctionSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Aug 23, 2011·1 cites·4 claims
- 0668US2011268817A1Compounds useful for the prevention or treatment of accomodative asthenopiaSIGMA TAU IND FARMACEUTI·Filed 2009·Application pending·0 cites
- 0767US9125903B2Composition useful for the treatment of lipid metabolism disordersKOVERECH ALEARDO·Filed 2012·Granted Sep 8, 2015·2 cites·11 claims
- 0860US2009042983A1Use of L-carnitine for the treatment of cardiovascular diseasesSIGMA TAU IND FARMACEUTI·Filed 2008·Application pending·0 cites
- 0960US2011217252A1Compound useful for treating celluliteSIGMA TAU IND FARMACEUTI·Filed 2009·Application pending·0 cites
- 1058US2014079809A1Compounds useful for the prevention or treatment of accommodative asthenopiaSIGMA TAU IND FARMACEUTI·Filed 2013·Application pending·0 cites
- 1157US11433043B2Compounds useful for increasing neurogenesis in neural tissueALFASIGMA SPA·Filed 2020·Granted Sep 6, 2022·0 cites·4 claims
- 1256US2013137651A1Gel useful for the delivery of ophthalmic drugsIND FARMACEUTICHE RIUNITE S P A SIGMA TAU·Filed 2013·Application pending·0 cites
- 1353US7879908B2Use of L-carnitine for the treatment of cardiovascular diseasesSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Feb 1, 2011·0 cites·6 claims
- 1453US2006052450A1Use of l-carnitine for the treatment of cardiovascular diseasesSIGMA TAU IND FARMACEUTI·Filed 2004·Application pending·0 cites
- 1552US8415392B2Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermiaCAVALLINI GIORGIO·Filed 2008·Granted Apr 9, 2013·0 cites·29 claims
- 1652US2014322149A1Compound useful for treating celluliteSIGMA TAU IND FARMACEUTI·Filed 2014·Application pending·0 cites
- 1751US9457037B2Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiencySIGMA TAU IND FARMACEUTI·Filed 2013·Granted Oct 4, 2016·0 cites·16 claims
- 1850US8343979B2Use of alkanoyl L-carnitine for the treatment of erectile dysfunctionSIGMA TAU IND FARMACEUTI·Filed 2011·Granted Jan 1, 2013·0 cites·1 claims
- 1950US2007117762A1Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunctionSIGMA TAU IND FARMACEUTI·Filed 2007·Application pending·0 cites
- 2048US9114120B2Therapeutical method for the treatment of the Leber optic neuropathyKOVERECH ALEARDO·Filed 2011·Granted Aug 25, 2015·0 cites·11 claims
- 2148US8394854B2Use of L-carnitine for the treatment of cardiovascular diseasesKOVERECH ALEARDO·Filed 2010·Granted Mar 12, 2013·0 cites·6 claims
- 2246US7956091B2Use of carnitines for the prevention and/or treatment of disorders caused by the andropauseSIGMA TAU IND FARMACEUTI·Filed 2003·Granted Jun 7, 2011·0 cites·8 claims
- 2346US7084174B2Administration of isovaleryl L-carnitine to stimulate osteoblastic activitySIGMA TAU IND FARMACEUTI·Filed 2005·Granted Aug 1, 2006·0 cites·5 claims
- 2444US8013016B2Use of acetyl L-carnitine for the treatment of fibromyalgic syndromeSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Sep 6, 2011·0 cites·3 claims
- 2544US7776913B2Carnitines for treating or preventing disorders caused by andropauseSIGMA TAU IND FARMACEUTI·Filed 2008·Granted Aug 17, 2010·0 cites·5 claims
- 2644US2014294922A1Compound with antibacterial activityKOVERECH ALEARDO·Filed 2011·Application pending·0 cites
- 2743US6906102B2Use of isovaleryl L-carnitine to increase healing of bone fracturesSIGMA TAU IND FARMACEUTI·Filed 2001·Granted Jun 14, 2005·0 cites·5 claims
- 2841US2011189152A1Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiencySIGMA TAU IND FARMACEUTI·Filed 2011·Application pending·0 cites
- 2941US2013005670A1COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCYSIGMA TAU IND FARMACEUTI·Filed 2011·Application pending·0 cites
- 3041US2005080018A1Use of alkanoyl l-carnitine for the treatment of erectile dysfunctionFiled 2002·Application pending·0 cites
- 3139US2005107470A1Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermiaSIGMA TAU IND FARMACEUTI·Filed 2003·Application pending·0 cites
- 3238US2016310458A1Compounds useful for increasing neurogenesis in neural tissueSIGMA TAU IND FARMACEUTI·Filed 2016·Application pending·0 cites
- 3335US2013045940A1Composition comprising as active ingredient l-carnitine in combination with a solar filter, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiationSIGMA TAU IND FARMACEUTI·Filed 2011·Application pending·0 cites
- 3435US2005038044A1Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's diseaseFiled 2002·Application pending·0 cites
- 3534US2013203848A1Compounds useful for increasing neurogenesis in neural tissueGRILLI MARIAGRAZIA·Filed 2011·Application pending·0 cites
- 3633US2014294921A1Composition for tipical use for treating skin disordersKOVERECH ALEARDO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aleardo Koverech files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →